Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Ewer · SciRah

Researcher profile · Semantic Scholar

M. Ewer

Share profile

M. Ewer — researcher profile on SciRah

h-index: 56
Works: 205
Citations: 20K

Most-cited papers

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J. Plana, M. Galderisi, A. Barac, M. Ewer +23 more
2014European Heart Journal-Cardiovascular Imaging1,379 citations Open access
Semantic Scholar
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.
S. Armenian, C. Lacchetti, A. Barac, J. Carver +17 more
2017Journal of Clinical Oncology1,138 citations
Semantic Scholar
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J. Plana, M. Galderisi, A. Barac, M. Ewer +23 more
2014Journal of the American Society of Echocardiography1,033 citations Open access
Semantic Scholar
Cardiotoxicity of anticancer treatments
M. Ewer, Steven M. Ewer
2015Nature Reviews Cardiology468 citations Open access
Semantic Scholar
Cancer drugs and the heart: importance and management.
T. Suter, M. Ewer
2013European Heart Journal434 citations Open access
Semantic Scholar
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
T. Eschenhagen, T. Force, M. Ewer, G. De Keulenaer +24 more
2011European Journal of Heart Failure405 citations
Semantic Scholar
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
M. Ewer, Steven M. Ewer
2010Nature Reviews Cardiology336 citations
Semantic Scholar
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer
E. Romond, Jong-Hyeon Jeong, P. Rastogi, S. Swain +17 more
2012Journal of Clinical Oncology317 citations Open access
Semantic Scholar
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
M. Piccart, M. Procter, D. Fumagalli, E. de Azambuja +24 more
2021Journal of Clinical Oncology304 citations Open access
Semantic Scholar
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study
S. Swain, M. Ewer, G. Viale, S. Delaloge +11 more
2017Annals of Oncology227 citations Open access
Semantic Scholar
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study.
S. Swain, M. Ewer, J. Cortés, D. Amadori +6 more
2013The Oncologist163 citations Open access
Semantic Scholar
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
A. Buzdar, V. Suman, F. Meric-Bernstam, A. Leitch +7 more
2013The Lancet Oncology155 citations Open access
Semantic Scholar
A woman's heart
M. Ewer, S. Glück
2009Cancer94 citations Open access
Semantic Scholar
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
Jennifer R. Brown, J. Moslehi, M. Ewer, S. O'Brien +23 more
2018British Journal of Haematology88 citations Open access
Semantic Scholar
Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: a comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac events.
M. Ewer, T. Suter, D. Lenihan, L. Niculescu +3 more
2014European Journal of Cancer82 citations
Semantic Scholar
Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.
M. Ewer, Steven M. Ewer
2010Journal of Clinical Oncology79 citations
Semantic Scholar
Cardiac Safety of Osimertinib: A Review of Data
M. Ewer, S. H. Tekumalla, A. Walding, K. Atuah
2020Journal of Clinical Oncology69 citations Open access
Semantic Scholar
Stress-Induced Cardiomyopathy in Cancer Patients.
D. Giza, J. Lopez-Mattei, P. Vejpongsa, Ezequiel Munoz +6 more
2017American Journal of Cardiology59 citations
Semantic Scholar
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
N. Pondé, I. Bradbury, M. Lambertini, M. Ewer +20 more
2017Breast Cancer Research and Treatment56 citations Open access
Semantic Scholar
A historical perspective of anthracycline cardiotoxicity.
M. Ewer, D. V. Von Hoff, R. Benjamin
2011Heart Failure Clinics53 citations
Semantic Scholar
The Impact of Adjuvant Endocrine Therapy on Cardiovascular Health
M. Ewer
200952 citations
Semantic Scholar
Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy.
N. Harbeck, M. Ewer, M. de Laurentiis, Thomas M. Suter +1 more
2011Annals of Oncology47 citations Open access
Semantic Scholar
Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs.
A. Naing, H. Veasey-Rodrigues, D. Hong, S. Fu +9 more
2012Annals of Oncology43 citations Open access
Semantic Scholar
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas
B. Cheson, S. O'Brien, M. Ewer, M. D. Goncalves +6 more
2018Clinical Lymphoma, Myeloma & Leukemia41 citations Open access
Semantic Scholar
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: An open label single arm phase II trial
Y. Oki, M. Ewer, D. Lenihan, M. Fisch +16 more
2014Clinical Lymphoma, Myeloma & Leukemia41 citations Open access
Semantic Scholar
Is cardiotoxicity being adequately assessed in current trials of cytotoxic and targeted agents in breast cancer?
S. Verma, M. Ewer
2011Annals of Oncology40 citations Open access
Semantic Scholar
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
D. Eiger, N. Pondé, D. Agbor-tarh, A. Moreno-Aspitia +12 more
2020British Journal of Cancer37 citations Open access
Semantic Scholar
Cardiac safety of afatinib: a review of data from clinical trials
M. Ewer, K. Patel, D. O’Brien, R. Lorence
2015Cardio-Oncology28 citations Open access
Semantic Scholar
Current practices in the management of adverse events associated with targeted therapies for advanced renal cell carcinoma: a national survey of oncologists
J. N. Ruiz, V. R. Belum, P. Creel, A. Cohn +2 more
2014Clinical Genitourinary Cancer28 citations Open access
Semantic Scholar
Cardiac dysfunction after cancer treatment.
M. Ewer, S. Swain, D. Cardinale, Anecita P. Fadol +1 more
2011Texas Heart Institute Journal23 citations
Semantic Scholar
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer
C. Dang, M. Ewer, S. Delaloge, J. Ferrero +10 more
2022Cancers22 citations Open access
Semantic Scholar
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
E. de Azambuja, E. Agostinetto, M. Procter, D. Eiger +17 more
2023ESMO Open21 citations Open access
Semantic Scholar
Abstract GS1-04: Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in patients with operable HER2-pos
M. Piccart, M. Procter, D. Fumagalli, E. de Azambuja +24 more
2020General Session Abstracts19 citations
Semantic Scholar
Report on the International Colloquium on Cardio-Oncology (Rome, 12–14 March 2014)
M. Ewer, L. Gianni, F. Pane, M. Sandri +18 more
2014ecancermedicalscience19 citations Open access
Semantic Scholar
Updated results from the international phase III ALTTO trial (BIG 2–06/Alliance N063D)
A. Moreno-Aspitia, E. Holmes, C. Jackisch, E. de Azambuja +25 more
2021European Journal of Cancer18 citations Open access
Semantic Scholar
Long-term cardiac safety of dose-dense anthracycline therapy cannot be predicted from early ejection fraction data.
M. Ewer, Steven M. Ewer
2009Journal of Clinical Oncology17 citations
Semantic Scholar
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Edward T. H. Yeh, M. Ewer, J. Moslehi, M. Długosz-Danecka +3 more
2019Seminars in Oncology16 citations Open access
Semantic Scholar
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in the CLEOPATRA study.
M. Ewer, J. Baselga, E. Clark, M. Benyunes +2 more
201216 citations
Semantic Scholar
Chemotherapy and QT Prolongation: Overview With Clinical Perspective
Peter Y. Kim, M. Ewer
2014Current Treatment Options in Cardiovascular Medicine14 citations
Semantic Scholar
False Positive Cardiotoxicity Events in Cancer-Related Clinical Trials: Risks Related to Imperfect Noninvasive Parameters
M. Ewer, J. Herson
2019Chemotherapy12 citations
Semantic Scholar
Cardio-oncology: an ongoing evolution.
B. Petek, C. Greenman, J. Herrmann, M. Ewer +1 more
2015Future Oncology12 citations
Semantic Scholar
TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients
D. Monlezun, Logan Hostetter, Prakash Balan, N. Palaskas +6 more
2020Cardio-Oncology9 citations Open access
Semantic Scholar
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
M. Ewer, J. Herson
2022Cardio-Oncology8 citations Open access
Semantic Scholar
Trastuzumab Cardiotoxicity After Anthracycline Exposure Constitutes a Complex and Clinically Important Entity.
M. Ewer, Steven M. Ewer
2019JACC. Heart failure8 citations Open access
Semantic Scholar
43O Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial
C. Dang, M. Ewer, S. Delaloge, J. Ferrero +9 more
20215 citations Open access
Semantic Scholar
The anthracycline-trastuzumab interaction: a lesson in not jumping to confusion.
M. Ewer, Steven M. Ewer
2015TIPS - Trends in Pharmacological Sciences5 citations
Semantic Scholar
Cardiac Effects of Cancer Therapy
J. Speyer, B. Kobrinsky, M. Ewer
20135 citations
Semantic Scholar
Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anticancer Treatments: Do the Data Support the Recommendations?
M. Ewer, N. Palaskas, J. Herson
2023Journal of Pharmacology and Experimental Therapeutics4 citations
Semantic Scholar
An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020
Anecita P. Fadol, N. Palaskas, M. Ewer, A. Deswal
2020Cardio-Oncology4 citations Open access
Semantic Scholar
Cancer and the Heart
M. Ewer
20194 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Steven M. Ewer×7
Invite
Steven M. Ewer — researcher profile on SciRah
T. Suter×7
Invite
T. Suter — researcher profile on SciRah
E. de Azambuja×7
Invite
E. de Azambuja — researcher profile on SciRah
S. Swain×7
Invite
S. Swain — researcher profile on SciRah

×5

Invite

G. Jerusalem — researcher profile on SciRah

D. Cardinale×4

Invite

D. Cardinale — researcher profile on SciRah

Invite

J. Carver — researcher profile on SciRah

Invite

T. Force — researcher profile on SciRah

Invite

S. Dent — researcher profile on SciRah

Invite

D. Lenihan — researcher profile on SciRah

Invite

M. Piccart — researcher profile on SciRah

D. Fumagalli×4

Invite

D. Fumagalli — researcher profile on SciRah